Sai Life Sciences will hold a board meeting on 14 May 2026 to approve audited financial results for Q4 and FY ended 31 March 2026.
The trading window for designated persons has been closed since 01 April 2026 and will reopen 48 hours after results declaration.
This notice is a mandatory regulatory disclosure under SEBI LODR Regulation 29 for informing exchanges about the scheduled board meeting.